Treatment of Severe DRESS Syndrome with Significant Hepatic Damage (Transaminases >15N or Factor V <50%)
This protocol covers the management of DRESS syndrome when it meets criteria for severity — particularly when marked hepatic injury is present, with or without additional organ involvement or macrophage activation syndrome.
Clinical Scenario
Severe DRESS is defined by one or more of the following features:
- Severe hepatic damage: transaminases >15× normal (N) and/or Factor V <50%
- Acute kidney injury: KDIGO III classification or rapid deterioration of renal function
- Organ involvement: lung, heart, digestive organs, or central nervous system
- Macrophage activation syndrome
Treatment Approach
Severe DRESS at this level of hepatic compromise warrants systemic corticosteroid therapy. The specific route, dosing, and tapering strategy are detailed in the full structured protocol — access it below.
References
- Severe DRESS is characterized by severe hepatic damage (transaminases > 15 N and/or Factor V < 50%), and/or acute kidney injury (with rapid deterioration of renal function or classified as KDIGO III [kdigo.org]), damage to certain organs (e.g., lung, heart, digestive organs, central nervous system), and/or the presence of macrophage activation syndrome.
- For severe DRESS, oral or intravenous corticosteroid therapy at 1 mg/kg/day prednisone equivalent is indicated, for an average duration of 1 month, with a very gradual taper over 3 to 6 months.
DOI: 10.1016/j.annder.2025.103381
View source ↗